KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Dillard'S (DDS) EBITDA (2016 - 2025)

Dillard'S (DDS) has disclosed EBITDA for 17 consecutive years, with $532.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA rose 12.53% year-over-year to $532.7 million, compared with a TTM value of $1.9 billion through Nov 2025, up 10.62%, and an annual FY2025 reading of $153.2 million, down 20.39% over the prior year.
  • EBITDA was $532.7 million for Q4 2025 at Dillard'S, up from $390.3 million in the prior quarter.
  • Across five years, EBITDA topped out at $532.7 million in Q4 2025 and bottomed at $146.6 million in Q1 2021.
  • Average EBITDA over 5 years is $354.4 million, with a median of $343.7 million recorded in 2022.
  • The sharpest move saw EBITDA soared 2005.82% in 2021, then decreased 26.57% in 2024.
  • Year by year, EBITDA stood at $286.6 million in 2021, then decreased by 6.01% to $269.4 million in 2022, then dropped by 9.81% to $242.9 million in 2023, then skyrocketed by 94.85% to $473.4 million in 2024, then grew by 12.53% to $532.7 million in 2025.
  • Business Quant data shows EBITDA for DDS at $532.7 million in Q4 2025, $390.3 million in Q3 2025, and $508.8 million in Q2 2025.